The perimenopause, depressive disorders, and hormonal variability
- PMID: 11276171
- PMCID: PMC11159580
- DOI: 10.1590/s1516-31802001000200008
The perimenopause, depressive disorders, and hormonal variability
Abstract
Context: Several investigations have postulated that the perimenopause may represent a period of increased psychiatric vulnerability, particularly for mood disorders. This review characterizes the perimenopause, including biological changes, the influence of psychosocial factors and the most common clinical manifestations. Clinic-based studies and community-based surveys addressing the prevalence of depressive symptoms in perimenopausal women are critically reviewed. We also discuss the potential greater vulnerability to mood disturbance during the perimenopause in response to hormonal variability. A therapeutic algorithm for management of depressive symptoms in middle-aged perimenopausal women is also presented. The role of estrogen in the treatment of perimenopausal depressive symptoms is particularly discussed. In addition, we review the existing data regarding the potential efficacy of estrogen as an antidepressant agent (monotherapy, augmentation strategy or prophylaxis).
Design: Narrative review.
CONTEXTO:: Diversos trabalhos têm apontado a peri-menopausa como um período de maior vulnerabilidade para o surgimento de transtornos psiquiátricos, particularmente os quadros depressivos. Esse artigo revisa, primeiramente, o conceito de peri-menopausa, descrevendo suas características clínicas, alterações biológicas e aspectos psicossociais. Estudos sobre a prevalência de transtornos depressivos durante a peri-menopausa, abordando diferentes sub-populações (mulheres atendidas em serviços ginecológicos especializados, estudos populacionais transversais e longitudinais), são discutidos de forma crítica. Nesse artigo também abordamos as alterações hormonais presentes durante a transição menopausal, e o seu possível papel de "gatilho" no surgimento/exacerbação de quadros depressivos. Apresentamos um modelo de abordagem terapêutica para os quadros depressivos surgidos entre mulheres na faixa etária correspondente à peri-menopausa. O papel da terapêutica de reposição hormonal, nesses quadros, é discutido através da revisão dos estudos existentes sobre o uso de estrógenos como agente antidepressivo (monoterapia, terapêutica adjuvante ou profilaxia).
TIPO DE ESTUDO:: Revisão narrativa
Conflict of interest statement
Similar articles
-
Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.Drugs Aging. 2003;20(2):85-100. doi: 10.2165/00002512-200320020-00001. Drugs Aging. 2003. PMID: 12534310 Review.
-
Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.Menopause. 2018 Oct;25(10):1069-1085. doi: 10.1097/GME.0000000000001174. Menopause. 2018. PMID: 30179986
-
Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations.J Womens Health (Larchmt). 2019 Feb;28(2):117-134. doi: 10.1089/jwh.2018.27099.mensocrec. Epub 2018 Sep 5. J Womens Health (Larchmt). 2019. PMID: 30182804
-
Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment.Harv Rev Psychiatry. 1998 Sep-Oct;6(3):121-32. doi: 10.3109/10673229809000320. Harv Rev Psychiatry. 1998. PMID: 10372280 Review.
-
[Mood disorders in perimenopausal women: hormone replacement or antidepressant therapy?].Rev Med Suisse. 2005 Sep 21;1(33):2155-6, 2159-61. Rev Med Suisse. 2005. PMID: 16223218 Review. French.
Cited by
-
Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.Front Neurosci. 2012 Jan 19;5:136. doi: 10.3389/fnins.2011.00136. eCollection 2011. Front Neurosci. 2012. PMID: 22294977 Free PMC article.
-
Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.Drugs Aging. 2003;20(2):85-100. doi: 10.2165/00002512-200320020-00001. Drugs Aging. 2003. PMID: 12534310 Review.
-
Cross-sectional and prospective relationships of endogenous progestogens and estrogens with glucose metabolism in men and women: a KORA F4/FF4 Study.BMJ Open Diabetes Res Care. 2021 Feb;9(1):e001951. doi: 10.1136/bmjdrc-2020-001951. BMJ Open Diabetes Res Care. 2021. PMID: 33574134 Free PMC article.
-
Morning and nocturnal serum melatonin rhythm levels in patients with major depressive disorder: an analytical cross-sectional study.Sao Paulo Med J. 2012;130(3):167-72. doi: 10.1590/s1516-31802012000300006. Sao Paulo Med J. 2012. PMID: 22790549 Free PMC article.
-
Combination/augmentation strategies for improving the treatment of depression.Neuropsychiatr Dis Treat. 2005 Dec;1(4):301-9. Neuropsychiatr Dis Treat. 2005. PMID: 18568111 Free PMC article.
References
-
- World Health Organization . Research on the menopause in the 1990s: report of a WHO scientific group. Geneva: WHO Technical Report Series number 866; 1996. - PubMed
-
- Teede H, Burger HG. The menopausal transition. In: Studd JWW, editor. The Management of Menopause - Annual Book Review. London, England: Parthenon Publishing Group; 1998. pp. 1–12.
-
- Schmidt PJ, Roca CA, Bloch M, Rubinow DR. The perimenopause and affective disorders. Semin Reprod Endocrinol. 1997;15(1):91–100. - PubMed
-
- The North American Menopause Society Clinical challenges of perimenopause: consensus opinion of the North American Menopause Society. Menopause. 2000;7:5–13. - PubMed
-
- Treolar AE. Menstrual cyclicity and the premenopause. Maturitas. 1981;3:249–264. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical